10367539

Source:http://linkedlifedata.com/resource/pubmed/id/10367539

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists.
Subject	Predicate	Object	Context
pubmed-article:10367539	rdf:type	pubmed:Citation	lld:pubmed
pubmed-article:10367539	lifeskim:mentions	umls-concept:C0087111	lld:lifeskim
pubmed-article:10367539	lifeskim:mentions	umls-concept:C0007138	lld:lifeskim
pubmed-article:10367539	lifeskim:mentions	umls-concept:C1522484	lld:lifeskim
pubmed-article:10367539	lifeskim:mentions	umls-concept:C0036525	lld:lifeskim
pubmed-article:10367539	lifeskim:mentions	umls-concept:C0045093	lld:lifeskim
pubmed-article:10367539	lifeskim:mentions	umls-concept:C0450442	lld:lifeskim
pubmed-article:10367539	lifeskim:mentions	umls-concept:C0282460	lld:lifeskim
pubmed-article:10367539	lifeskim:mentions	umls-concept:C0205171	lld:lifeskim
pubmed-article:10367539	pubmed:issue	1	lld:pubmed
pubmed-article:10367539	pubmed:dateCreated	1999-7-8	lld:pubmed
pubmed-article:10367539	pubmed:abstractText	To evaluate the therapeutic activity and toxicity of gemcitabine in the treatment of metastatic urothelial carcinoma.	lld:pubmed
pubmed-article:10367539	pubmed:language	eng	lld:pubmed
pubmed-article:10367539	pubmed:journal	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:10367539	pubmed:citationSubset	IM	lld:pubmed
pubmed-article:10367539	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:10367539	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:10367539	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:10367539	pubmed:status	MEDLINE	lld:pubmed
pubmed-article:10367539	pubmed:issn	0009-9074	lld:pubmed
pubmed-article:10367539	pubmed:author	pubmed-author:MauceriGG	lld:pubmed
pubmed-article:10367539	pubmed:author	pubmed-author:TestaAA	lld:pubmed
pubmed-article:10367539	pubmed:author	pubmed-author:GebbiaVV	lld:pubmed
pubmed-article:10367539	pubmed:author	pubmed-author:BorsellinoNN	lld:pubmed
pubmed-article:10367539	pubmed:author	pubmed-author:VarvaraFF	lld:pubmed
pubmed-article:10367539	pubmed:author	pubmed-author:SambataroDD	lld:pubmed
pubmed-article:10367539	pubmed:author	pubmed-author:TirritoM LML	lld:pubmed
pubmed-article:10367539	pubmed:author	pubmed-author:FallicaGG	lld:pubmed
pubmed-article:10367539	pubmed:issnType	Print	lld:pubmed
pubmed-article:10367539	pubmed:volume	150	lld:pubmed
pubmed-article:10367539	pubmed:owner	NLM	lld:pubmed
pubmed-article:10367539	pubmed:authorsComplete	Y	lld:pubmed
pubmed-article:10367539	pubmed:pagination	11-5	lld:pubmed
pubmed-article:10367539	pubmed:dateRevised	2006-11-15	lld:pubmed
pubmed-article:10367539	pubmed:meshHeading	pubmed-meshheading:10367539...	lld:pubmed
pubmed-article:10367539	pubmed:meshHeading	pubmed-meshheading:10367539...	lld:pubmed
pubmed-article:10367539	pubmed:meshHeading	pubmed-meshheading:10367539...	lld:pubmed
pubmed-article:10367539	pubmed:meshHeading	pubmed-meshheading:10367539...	lld:pubmed
pubmed-article:10367539	pubmed:meshHeading	pubmed-meshheading:10367539...	lld:pubmed
pubmed-article:10367539	pubmed:meshHeading	pubmed-meshheading:10367539...	lld:pubmed
pubmed-article:10367539	pubmed:articleTitle	Single agent 2',2'-difluorodeoxycytidine in the treatment of metastatic urothelial carcinoma: a phase II study.	lld:pubmed
pubmed-article:10367539	pubmed:affiliation	Division Medical Oncology, Centro Catanese di Oncologia, Catania, Italy.	lld:pubmed
pubmed-article:10367539	pubmed:publicationType	Journal Article	lld:pubmed
pubmed-article:10367539	pubmed:publicationType	Clinical Trial	lld:pubmed
pubmed-article:10367539	pubmed:publicationType	Randomized Controlled Trial	lld:pubmed
pubmed-article:10367539	pubmed:publicationType	Clinical Trial, Phase II	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:10367539	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:10367539	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:10367539	lld:pubmed